» Articles » PMID: 19965718

Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection

Overview
Journal Science
Specialty Science
Date 2009 Dec 8
PMID 19965718
Citations 757
Authors
Affiliations
Soon will be listed here.
Abstract

The liver-expressed microRNA-122 (miR-122) is essential for hepatitis C virus (HCV) RNA accumulation in cultured liver cells, but its potential as a target for antiviral intervention has not been assessed. We found that treatment of chronically infected chimpanzees with a locked nucleic acid (LNA)-modified oligonucleotide (SPC3649) complementary to miR-122 leads to long-lasting suppression of HCV viremia, with no evidence of viral resistance or side effects in the treated animals. Furthermore, transcriptome and histological analyses of liver biopsies demonstrated derepression of target mRNAs with miR-122 seed sites, down-regulation of interferon-regulated genes, and improvement of HCV-induced liver pathology. The prolonged virological response to SPC3649 treatment without HCV rebound holds promise of a new antiviral therapy with a high barrier to resistance.

Citing Articles

MicroRNA Gets a Mighty Award.

Li Y, Chen S, Rao H, Cui S, Chen G Adv Sci (Weinh). 2025; 12(7):e2414625.

PMID: 39836690 PMC: 11831481. DOI: 10.1002/advs.202414625.


Viral RNA Interactome: The Ultimate Researcher's Guide to RNA-Protein Interactions.

Hanson W, Romero Agosto G, Rouskin S Viruses. 2024; 16(11).

PMID: 39599817 PMC: 11599142. DOI: 10.3390/v16111702.


MicroRNA-122 protects against interferon-α-induced hepatic inflammatory response via the Janus kinase-signal transducer and activator of transcription pathway.

Liu F, Liu B, Xu S, Ni Y, Liu X Endocr J. 2024; 72(1):53-67.

PMID: 39358210 PMC: 11778391. DOI: 10.1507/endocrj.EJ24-0317.


Hepatic miR-149-5p upregulation fosters steatosis, inflammation and fibrosis development in mice and in human liver organoids.

Correia de Sousa M, Delangre E, Berthou F, El Harane S, Maeder C, Fournier M JHEP Rep. 2024; 6(9):101126.

PMID: 39263327 PMC: 11388170. DOI: 10.1016/j.jhepr.2024.101126.


Autophagy-associated non-coding RNAs: Unraveling their impact on Parkinson's disease pathogenesis.

Hussain M, Moglad E, Afzal M, Sharma S, Gupta G, Sivaprasad G CNS Neurosci Ther. 2024; 30(5):e14763.

PMID: 38790149 PMC: 11126788. DOI: 10.1111/cns.14763.


References
1.
Feld J, Hoofnagle J . Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature. 2005; 436(7053):967-72. DOI: 10.1038/nature04082. View

2.
Chen L, Borozan I, Feld J, Sun J, Tannis L, Coltescu C . Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology. 2005; 128(5):1437-44. DOI: 10.1053/j.gastro.2005.01.059. View

3.
Chen C, He Y, Lu L, Lim H, Tripathi R, Middleton T . Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee model. Antimicrob Agents Chemother. 2007; 51(12):4290-6. PMC: 2167986. DOI: 10.1128/AAC.00723-07. View

4.
Chisari F . Unscrambling hepatitis C virus-host interactions. Nature. 2005; 436(7053):930-2. DOI: 10.1038/nature04076. View

5.
Elmen J, Lindow M, Silahtaroglu A, Bak M, Christensen M, Lind-Thomsen A . Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 2007; 36(4):1153-62. PMC: 2275095. DOI: 10.1093/nar/gkm1113. View